4/A

FORM 4/A SUBMISSION

Company: KalVista Pharmaceuticals, Inc.
Filed: April 27, 2015
Period of Report: April 14, 2015
Accession Number: 0001209191-15-036341

View Document ↗ View on SEC.gov ↗